Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. M. Lin, C. H. Wang, H. P. Kuo (Taipei, Taiwan). Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization. Eur Respir J 2014; 44: Suppl. 58, 2999

Member's Comments

No comment yet.

Related content which might interest you: Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 The course and outcomes of pregnancy in women with bronchial asthma Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Assessment of mis-beliefs about bronchial asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children Source: International Congress 2014 – More paediatric asthma Year: 2014 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Influence of maternal bronchial asthma clinical phenotype on development of allergies in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab Source: International Congress 2014 – More paediatric asthma Year: 2014 Evaluating omalizumab persistency of response after long-term therapy (XPORT) Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 When needed use of inhaled steroids in children with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 The impact of sublingual allergen-specific therapy on asthma control and quality of life Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Airway hyperresponsiveness in patients treated with omalizumab Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Occupational asthma as a result of severe asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015